Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / MED BREAKTHGH
-
Total 13F shares
-
1,344,986
-
Share change
-
-60,935
-
Total reported value
-
$36,611,445
-
Put/Call ratio
-
34%
-
Price per share
-
$27.22
-
Number of holders
-
35
-
Value change
-
-$2,061,644
-
Number of buys
-
15
-
Number of sells
-
15
Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q3 2023
As of 30 Sep 2023,
ALPS ETF TR - MED BREAKTHGH (SBIO) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,344,986 shares.
The largest 10 holders included
DAVENPORT & Co LLC, BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, Strategic Financial Services, Inc,, WELLS FARGO & COMPANY/MN, NTV Asset Management LLC, Royal Bank of Canada, CITADEL ADVISORS LLC, and LPL Financial LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.